Resonance Health Limited (ASX:RHT)
0.0400
0.00 (0.00%)
At close: Mar 6, 2026
Resonance Health Revenue
Resonance Health had revenue of 5.86M AUD in the half year ending June 30, 2025, with 154.43% growth. This brings the company's revenue in the last twelve months to 13.79M, up 30.17% year-over-year. In the fiscal year ending June 30, 2025, Resonance Health had annual revenue of 11.07M with 28.91% growth.
Revenue (ttm)
13.79M
Revenue Growth
+30.17%
P/S Ratio
1.38
Revenue / Employee
864.85K
Employees
16
Market Cap
19.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 11.07M | 2.48M | 28.91% |
| Jun 30, 2024 | 8.59M | 4.19M | 95.02% |
| Jun 30, 2023 | 4.40M | 551.38K | 14.31% |
| Jun 30, 2022 | 3.85M | 74.06K | 1.96% |
| Jun 30, 2021 | 3.78M | 110.73K | 3.02% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ImExHS | 28.97M |
| Pathkey.AI | 290.26K |
| Adheris Health | 40.60M |
| TrivarX | -95.36K |
| Intelicare Holdings | 945.45K |
| HITIQ | 1.98M |
| PainChek | 3.44M |
| Emyria | 2.29M |